These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. In vivo use of rapamycin suppresses neither IL-2 production nor IL-2 receptor expression in rat transplant model. Hamashima T; Yoshimura N; Ohsaka Y; Oka T; Stepkowski SM; Kahan BD Transplant Proc; 1993 Feb; 25(1 Pt 1):723-4. PubMed ID: 8438457 [No Abstract] [Full Text] [Related]
4. Efficacy and mechanism of action of rapamycin in presensitized recipients of experimental allografts. Chen H; Wu J; Xu D; Luo H; Daloze P Transplant Proc; 1992 Oct; 24(5):1669-70. PubMed ID: 1412790 [No Abstract] [Full Text] [Related]
5. Cytokine and alloantibody networks in long-term cardiac allografts in rapamycin-treated sensitized rat recipients. Wasowska B; Wieder KJ; Hancock WW; Berse B; Binder J; Strom TB; Kupiec-Weglinski JW Transplant Proc; 1995 Feb; 27(1):423-6. PubMed ID: 7879047 [No Abstract] [Full Text] [Related]
6. Interaction between rapamycin and pretransplant blood transfusions in rat heterotopic heart transplantation. Tucker MJ; Duplan J; Li X; Garcia B; Wijsman J; Stiller C; McKenzie FN Transplant Proc; 1993 Feb; 25(1 Pt 1):725-6. PubMed ID: 8438458 [No Abstract] [Full Text] [Related]
7. Reversal of ongoing rejection of allografts by rapamycin. Chen HF; Wu JP; Luo HY; Daloze PM Transplant Proc; 1991 Aug; 23(4):2241-2. PubMed ID: 1871859 [No Abstract] [Full Text] [Related]
8. Rapamycin treatment depresses intragraft expression of KC/MIP-2, granzyme B, and IFN-gamma in rat recipients of cardiac allografts. Wieder KJ; Hancock WW; Schmidbauer G; Corpier CL; Wieder I; Kobzik L; Strom TB; Kupiec-Weglinski JW J Immunol; 1993 Jul; 151(2):1158-66. PubMed ID: 8335897 [TBL] [Abstract][Full Text] [Related]
9. Cytokine and alloantibody networks in long term cardiac allografts in rat recipients treated with rapamycin. Wasowska B; Wieder KJ; Hancock WW; Zheng XX; Berse B; Binder J; Strom TB; Kupiec-Weglinski JW J Immunol; 1996 Jan; 156(1):395-404. PubMed ID: 8598490 [TBL] [Abstract][Full Text] [Related]
10. Donor pretreatment with methylprednisolone synergistically prolongs survival of cardiac allografts in sensitized rat recipients conditioned with rapamycin. Schmidbauer G; Homeyer A; Bohle RM; Grimm H; Binder J; Kupiec-Weglinski JW Transplant Proc; 1997; 29(1-2):607-8. PubMed ID: 9123151 [No Abstract] [Full Text] [Related]
11. Donor pretreatment with rapamycin delays rejection following intestinal allotransplantation. He G; Zhong R; Zhang Z; Garcia B; Black R; Duff J; Grant D Transplant Proc; 1992 Jun; 24(3):1178. PubMed ID: 1604577 [No Abstract] [Full Text] [Related]
12. Immunosuppressive effects of leflunomide in a cardiac allograft model. Williams JW; Xiao F; Foster PF; Chong A; Sharma S; Bartlett R; Sankary HN Transplant Proc; 1993 Feb; 25(1 Pt 1):745-6. PubMed ID: 8438465 [No Abstract] [Full Text] [Related]
13. Studies in experimental models of chronic rejection: use of rapamycin (sirolimus) and isoxazole derivatives (leflunomide and its analogue) for the suppression of graft vascular disease and obliterative bronchiolitis. Morris RE; Huang X; Gregory CR; Billingham ME; Rowan R; Shorthouse R; Berry GJ Transplant Proc; 1995 Jun; 27(3):2068-9. PubMed ID: 7792888 [No Abstract] [Full Text] [Related]
15. Effect of steroids on cellular proliferation in rat cardiac allografts. Ruers TJ; Buurman W; Kootstra G Transplant Proc; 1991 Feb; 23(1 Pt 1):488. PubMed ID: 1990594 [No Abstract] [Full Text] [Related]
16. Route of administration determines the efficacy of rapamycin but not the mechanisms of tolerance induced by it in rats. Lin Y; Rutgeerts O; Waer M Transplant Proc; 1996 Dec; 28(6):3057. PubMed ID: 8962185 [No Abstract] [Full Text] [Related]
17. Interaction of diltiazem and rapamycin on survival of rat cardiac allografts. Dumont L; Chen H; Xu D; Daloze P Ann N Y Acad Sci; 1993 Nov; 696():392-5. PubMed ID: 8109847 [No Abstract] [Full Text] [Related]
18. SK&F 105685 suppresses allogeneically induced mononuclear and endothelial cell activation and cytokine production and prolongs rat cardiac allograft survival. Hancock WW; Schmidbauer G; Badger AM; Kupiec-Weglinski JW Transplant Proc; 1992 Feb; 24(1):231-2. PubMed ID: 1539260 [No Abstract] [Full Text] [Related]
19. Effects of rapamycin on renal microsomal P-450 systems in the rat. Yoshimura R; Yoshimura N; Ohyama A; Tsujino T; Kusunose E; Nakatani T; Kahan BD; Stepkowski SM; Kishimoto T Transplant Proc; 1993 Feb; 25(1 Pt 1):750-1. PubMed ID: 8438468 [No Abstract] [Full Text] [Related]
20. Rapamycin (Sirolimus) inhibits vascular smooth muscle DNA synthesis in vitro and suppresses narrowing in arterial allografts and in balloon-injured carotid arteries: evidence that rapamycin antagonizes growth factor action on immune and nonimmune cells. Morris RE; Cao W; Huang X; Gregory CR; Billingham ME; Rowan R; Shorthouse RA Transplant Proc; 1995 Feb; 27(1):430-1. PubMed ID: 7879049 [No Abstract] [Full Text] [Related] [Next] [New Search]